Clinical Trial Search Results
Not finding what you’re looking for? Try expanding your search to broader disease categories, locations or trials types. For studies outside of Oregon, see clinical trials listed with the National Cancer Institute.
| Cancer Site(s): | All Disease Types |
| Trial Type: | All Studies |
| Study Status: | Open |
| Doctor/Investigator: | Any |
| Age Group: | Any |
| Keywords: |
Refine Search | Start New Search |
Download search results to Excel|
Health Beliefs, Level of Acculturation, and Pap Smear Use among Latinos from Mexico
|
|
| Doctor/Investigator: | Jessica Gregg |
| Trial Type: | Observational Population Studies |
| Organization: | Knight (OHSU) |
| Cancer Site: | Cervix |
| Study Status: | Open |
| Age Group: | Adult |
| Knight Cancer Institute Number: CPC-07095-L | |
|
Phase I/II Study of (SAHA) Vorinostat, Cladribine, and Rituximab (SCR) in Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia, and Relap (...)
|
|
| Doctor/Investigator: | Stephen Spurgeon |
| Trial Type: | Treatment |
| Organization: | Knight (OHSU) |
| Cancer Site: | Lymphoma |
| Study Status: | Open |
| Age Group: | Adult |
| Knight Cancer Institute Number: HEM-08002-LM | |
|
A Phase I Study of GNKG16 Administered by Intravenous Infusion in Patients with Relapsed or Refractory B-Cell Chronic Lymphocytic Leuke (...)
|
|
| Doctor/Investigator: | Stephen Spurgeon |
| Trial Type: | Treatment |
| Organization: | Knight (OHSU) |
| Cancer Site: | Lymphoid Leukemia (CLL or ALL) |
| Study Status: | Open |
| Age Group: | Adult |
| Knight Cancer Institute Number: HEM-10086-P | |
|
A Phase II Proof of Concept Trial to Study Kinase Inhibition in Relapsed/Refractory Acute Leukemias: Using a Comprehensive in Vitro Kin (...)
|
|
| Doctor/Investigator: | Stephen Spurgeon |
| Trial Type: | Treatment |
| Organization: | Knight (OHSU) |
| Cancer Site: | Hematologic - other |
| Study Status: | Open |
| Age Group: | Adult |
| Knight Cancer Institute Number: HEM-11023-L | |
|
A Phase II Study of Dasatinib in Chronic Lymphocytic Leukemia in Patients who Exhibit in Vitro Dasatinib Sensitivity
|
|
| Doctor/Investigator: | Stephen Spurgeon |
| Trial Type: | Treatment |
| Organization: | Knight (OHSU) |
| Cancer Site: | Lymphoid Leukemia (CLL or ALL) |
| Study Status: | Open |
| Age Group: | Adult |
| Knight Cancer Institute Number: HEM-10010-L | |
|
A Phase II Study of CTLA Blockade by Ipilimumab, with and without Radiation Therapy, in Patients with an Incomplete Response to Androge (...)
|
|
| Doctor/Investigator: | Julie Graff |
| Trial Type: | Treatment |
| Organization: | Knight (OHSU) |
| Cancer Site: | Prostate |
| Study Status: | Open |
| Age Group: | Adult |
| Knight Cancer Institute Number: SOL-09030-LM | |
|
A Phase 1 Study of MLN8237, an Aurora A Kinase Inhibitor, in Patients with Advanced Solid Tumors Including Castration-Resistant Prostat (...)
|
|
| Doctor/Investigator: | Julie Graff |
| Trial Type: | Treatment |
| Organization: | Knight (OHSU) |
| Cancer Site: | Multiple Disease Sites |
| Study Status: | Open |
| Age Group: | Adult |
| Knight Cancer Institute Number: SOL-11075-P | |
|
Pilot Study of DCE-MRI, DW-MRI, and MRS in the Assessment of Head and Neck Cancer Response to Chemo-radiation
|
|
| Doctor/Investigator: | James Tanyi |
| Trial Type: | Screening/Detection/Diagnosis |
| Organization: | Knight (OHSU) |
| Cancer Site: | Head/Neck/Oral |
| Study Status: | Open |
| Age Group: | Adult |
| Knight Cancer Institute Number: CPC-09084-L | |
|
Pilot Study on the Quantification of Respiratory-induced Prostate Motion during Radiation Therapy using Continuous Real-time Tracking
|
|
| Doctor/Investigator: | James Tanyi |
| Trial Type: | Observational Population Studies |
| Organization: | Knight (OHSU) |
| Cancer Site: | Prostate |
| Study Status: | Open |
| Age Group: | Adult |
| Knight Cancer Institute Number: CPC-09097-L | |
|
Implications of MLC width on dose distribution
|
|
| Doctor/Investigator: | James Tanyi |
| Trial Type: | Observational Population Studies |
| Organization: | Knight (OHSU) |
| Cancer Site: | Multiple Disease Sites |
| Study Status: | Open |
| Age Group: | Adult |
| Knight Cancer Institute Number: CPC-08046-L | |
